The question of whether upper airway resistance syndrome (UARS) is a distinct disease or an initial feature of obstructive sleep apnoea syndrome is still a matter of debate. We evaluated a retrospective group of UARS patients to determine the evolution of UARS over time and the relationship between clinical evolution and subjects' phenotype. Investigations were performed in 30 patients, in whom UARS was diagnosed between 1995 and 2000 by the use of full polysomnography (PSG) without oesophageal pressure (Pes) measurement. The time between initial and follow-up investigations was 6.6 +/- 2.6 years. All subjects had full PSG with Pes measurement and completed a sleep questionnaire, including the Epworth Sleepiness Scale. In 19 subjects, PSG results were compatible with UARS. In nine subjects, obstructive sleep apnoea-hypopnoea syndrome (OSAHS) was diagnosed. In two subjects, PSG did not demonstrate breathing abnormalities. The mean +/- SD apnoea-hypopnoea index in the UARS group was 1.5 +/- 1.7 h(-1) and 25.2 +/- 19 h(-1) in the OSAHS group (P < 0.01). The increase in body mass index (BMI) between initial and follow-up investigations in the UARS group was from 29.4 +/- 4 to 31 +/- 5.7 kg m(-2) (P = 0.014) and in the OSAHS group from 30 +/- 4.1 to 32.4 +/- 4.7 kg m(-2)(P = 0.004). Amplitude of Pes swings during respiratory events was significantly higher in OSAHS than that in UARS (P = 0.014). Our results suggest that UARS is part of a clinical continuum from habitual snoring to OSAHS. Progression from UARS to OSAHS seems to be related to an increase in the BMI.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2869.2009.00734.xDOI Listing

Publication Analysis

Top Keywords

uars
10
upper airway
8
airway resistance
8
resistance syndrome
8
obstructive sleep
8
pes measurement
8
initial follow-up
8
follow-up investigations
8
+/-
8
subjects psg
8

Similar Publications

Obstructive sleep apnoea syndrome (OSA) is a multi-factorial disorder, with quite complex endotypes, consisting of anatomical and non-anatomical pathophysiological factors. Continuous positive airway pressure (CPAP) is recognized as the first-line standard treatment for OSA, whereas upper airway (UA) surgery is often recommended for treating mild OSA patients who have refused or cannot tolerate CPAP, mild and primary snorers. The main results achievable by the surgery are UA expansion, and/or stabilization, and/or removal of the obstructive tissue to different UA levels.

View Article and Find Full Text PDF

Assessing the Pathophysiology, Morbidity, and Mortality of Obstructive Sleep Apnea.

J Insur Med

November 2024

Editor-in-Chief, Journal of Insurance Medicine Email:

Article Synopsis
  • The text covers the definitions, prevalence, symptoms, and complications of obstructive sleep apnea (OSA).
  • It highlights the importance of understanding different phenotypes of chronic obstructive pulmonary disease (COPD) that can aid in treating OSA effectively and potentially reduce mortality.
  • The article aims to serve as a comprehensive reference for medical directors and underwriters in life and disability insurance when evaluating applicants with sleep apnea, backed by extensive references for further research.
View Article and Find Full Text PDF

Obstructive sleep apnea (OSA) is caused by temporary partial or complete constriction of the upper airway during sleep which leads to reduced blood oxygen and cardiovascular risks. Main symptoms vary between adults and children leading to misdiagnosis or delayed patient identification. To improve early diagnosis, lateral cephalograms can provide craniofacial measurements associated with a higher risk of OSA.

View Article and Find Full Text PDF
Article Synopsis
  • The study combined ultrasound-assisted rapidly synergistic cloud point extraction (UARS-CPE) with inductively coupled plasma optical emission spectrometry (ICP-OES) to measure trace lead (Pb) in Gentiana rigescens samples.
  • The method achieved a notable enhancement factor of 33 and very low limits of detection (0.11 μg L) and quantitation (0.37 μg L), with 1.3% precision, correlating well with results from ICP-MS.
  • In a mice model for immune liver injury, exposure to high doses of Pb (25 and 125 mg kg) significantly reduced the liver protective effects of G. rigescens and gentiopicroside (GPS), while a
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!